Browsing by Author Gebski, Val

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 198 < previous   next >
Issue DateTitleAuthor(s)Citation
2002The Chinese herbal formulation Biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trialGebski, Val; Grayson, David; Hu, Guo; Jones, Mark; Walls, Ronald; Bass, Diana; Bullock, Ramon; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: MedicineThe Chinese herbal formulation Biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial, Annals of Allergy, Asthma, & Immunology, vol.88,(5),2002,pp 478-487
2015Clinical trials of interventional oncology-moving from efficacy to outcomesGebski, Val; Franklin, James; Poston, Graeme J.; Sharma, Ricky; NH&MRC Clinical Trials CentreClinical trials of interventional oncology-moving from efficacy to outcomes, Nature Reviews Clinical Oncology, vol.12, 2, 2015,pp 93-104
2017COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention studyGebski, Val; Seppelt, Ian; Aneman, Anders; Brieva, Jorge L; Cavazzoni, Elena; Cheng, Andrew T H; Elliott, Rosalind; Herkes, Robert; O'Leary, Michael; Perry, Lin; Potter, J; NH&MRC Clinical Trials Centre; Nepean Clinical School: MedicineCOMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study, BMC Health Services Research, vol.17, 1, 2017,pp 1-10
2007A comparator study of pentosan polysulfate and carprofen on the clinical signs of pain and lameness in osteoarthritisGebski, Val; Brunnberg, Leo; Cullis-Hill, David; Hannon, Robert Logan; Smith, Jennifer Gaye; School of Public Health: NH&MRC Clinical Trials CentreA comparator study of pentosan polysulfate and carprofen on the clinical signs of pain and lameness in osteoarthritis, Kleintier-Praxis, vol.52,(3),2007,pp 133-142
2008Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)Coskinas, Xanthi; Gebski, Val; Simes, Robert John; Smith, Michaella; Sourjina, Tatiana; Stockler, Martin; Ung, Owen; Campbell, Ian; Gill, P Grantley; Kollias, James; Macphee, Avis; Wetzig, Neil R; Young, Leonie; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: SurgeryComparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial), Breast Cancer Research and Treatment, vol.Online (117), (1), 2008,pp 1 (99)-11 (109)
2010Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized TrialBoland, Amy L.; Boyer, Michael; Gebski, Val; Grimison, Peter; Gurney, Howard; Simes, Robert John; Stockler, Martin; Craft, Paul; Harvey, V; Levi, John; Lewis, Craig; Olver, Ian N; Thomson, Damien; Toner, Guy C.; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial, Journal of the National Cancer Institute, vol.102, 16, 2010,pp 1253-1262
2015Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerGebski, Val; Lee, Chee Khoon; Mann, Kristy; Simes, Robert John; Wilson, Kate; Bruhn, M; Cunningham, David; Hardingham, Jennifer; Price, Timothy; Robinson, B; Tebbutt, Niall; Townsend, Amanda; van Hazel, Guy; Weickhardt, Andrew; Wrin, Joseph; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreCorrelation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer, British Journal of Cancer, vol.112, 6, 2015,pp 963-970
2013The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancerGebski, Val; Graves, Nicholas; Janda, Monica; Merollini, Katharina; Obermair, Andreas; School of Public Health: NH&MRC Clinical Trials CentreThe cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer, BMJ Open, vol.3, 4, 2013,pp 1-5
2002Delay in the clinical diagnosis of breast cancer: estimating its effect on prognosis, with particular reference to medical litigationGebski, Val; Langlands, Allan; Tattersall, Martin; Hirsch, D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineDelay in the clinical diagnosis of breast cancer: estimating its effect on prognosis, with particular reference to medical litigation, Breast, vol.11,(5),2002,pp 386-393
2017Delayed versus Immediate Cord Clamping in Preterm InfantsAskie, Lisa; Brown, Rebecca; Evans, Nicholas; Finlayson, Sarah; Fogarty, Michael; Gebski, Val; Ghadge, Alpana; Hague, Wendy; Isaacs, David; Jeffery, Michele; Keech, Anthony (Tony); Kirby, Adrienne; Kluckow, Martin; Liley, Helen; Morris, Jonathan; Osborn, David; Popat, Himanshu; Robledo, Kristy; Sebastian, Lucille; Simes, Robert John; Tarnow-Mordi, William; Aagaard, K; Abdel-Latif, Mohamed E; Ariff, Shabina; Belfort, M; Chen, Y; Colditz, Paul B.; et al, Various; Pammi, M; Reynolds, G; Sheikh, L; NH&MRC Clinical Trials Centre; School of Public Health: Public Health; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; Central Clinical School: Obstetrics & Gynaecology; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreDelayed versus Immediate Cord Clamping in Preterm Infants, New England Journal of Medicine, vol.377, 25, 2017,pp 2445-2455
2003Determining the sample size in a clinical trial [in reply]Gebski, Val; Keech, Anthony (Tony); Kirby, Adrienne; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDetermining the sample size in a clinical trial [in reply], Medical Journal of Australia, vol.178,(7),2003,pp 358-358
2007Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsGebski, Val; Alsner, Jan; Eriksen, Jesper Grau; Horsman, Michael; Nordsmark, Marienne; Overgaard, Jens; School of Public Health: NH&MRC Clinical Trials CentreDifferential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients, Radiotherapy & Oncology, vol.83,(3),2007,pp 389-397
2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trialGebski, Val; Parry, M M; Pavlakis, Nick; Zannino, Diana; Dobrovic, Alexander N; Ganju, V.; Mellor, D; Strickland, A. H.; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreDocetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial, British Journal of Cancer, vol.108, 4, 2013,pp 771-774
2016Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE studyBalleine, Rosemary; Gao, Bo-Fu; Gebski, Val; Gurney, Howard; Hui, Rina; Kefford, Richard (Rick); Lee, Clara; Liddle, Christopher; Menzies, Alexander Maxwel; Provan, Pamela; Wilcken, Nicholas; Wong, Ka (Mark); Ali, Sayed Sahanawaz; Balakrishnar, Bavanthi; Coulter, Sally A.; Fox, Peter; Lynch, Jodi; Yeap, Shang Heng; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study, Clinical Cancer Research, vol.22, 13, 2016,pp 3164-3171
2017Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringGebski, Val; Liddle, Christopher; Balakrishnar, Bavanthi; Chan, Mathew; Coulter, Sally A.; Fox, Peter; Gurney, Howard; Sabanathan, Dhanusha; Zhang, Alison; NH&MRC Clinical Trials Centre; Westmead Clinical School: MedicineDose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring, Cancer Chemotherapy and Pharmacology, vol.80, 2, 2017,pp 385-393
2004Driving and Patients with Brain Tumours: a postal survey of Neurosurgeons, Neurologists and Radiation OncologistsCakir, Burcu; Clouston, Paul; Gebski, Val; Chin, Y. S.; Jayamohan, Jay; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials CentreDriving and Patients with Brain Tumours: a postal survey of Neurosurgeons, Neurologists and Radiation Oncologists, Journal of Clinical Neuroscience, vol.11,(5),2004,pp 471-474
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerPavlakis, Nick; Azad, Arun; Chong, Geoff; Dobrovic, Alexander; Fluck, Kate; Gebski, Val; Johns, Terrance G; Mariadason, John M; Price, Timothy; Salemi, R; Scott, Andrew M; Skrinos, Effie; Tebbutt, Niall; Weickhardt, Andrew J; Northern Clinical School: MedicineDual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer, Journal of Clinical Oncology, vol.30, 13, 2012,pp 1505-1512
2005Dynamic balancing randomization in controlled clinical trials.Gebski, Val; Heritier, Stephane; Pillai, Avineshwaran; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; FMO Audio VisualDynamic balancing randomization in controlled clinical trials., Statistics in Medicine, vol.24,(24),2005,pp 3729-3741
2011Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.Brown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Delva, Remy; Donadello, Nicoletta; Friedlander, Michael L.; Georgoulopoulos, Alexander; Mirza, Mansoor Raza; Pignata, Sandro; Pujade-Lauraine, Eric; Schmalfeldt, Barbara; Southier, Philippe; Vergote, Ignace; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer., Journal of the National Cancer Institute, vol.103, 17, 2011,pp 1338-1342
2013Early-stage squamous cell carcinoma of the lip: The Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resectionCross, Shamira; Gebski, Val; Morgan, Gary; Najim, Maria; Palme, Carsten; Veness, Michael; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School (Westmead): Office; Western Clinical School: Surgery; Western Clinical School: Medicine (Westmead)Early-stage squamous cell carcinoma of the lip: The Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection, Head and Neck, vol.35, 10, 2013,pp 1426-1430